Jim

Former Qualcomm Executive, Jim Tran, Joins TDK as CEO, TDK U.S.A. Corporation

Retrieved on: 
Tuesday, August 24, 2021

TDK Corporation (TSE:6762) announced today the appointment of Mr. Jim Tran to General Manager, Americas HQ and CEO TDK U.S.A.

Key Points: 
  • TDK Corporation (TSE:6762) announced today the appointment of Mr. Jim Tran to General Manager, Americas HQ and CEO TDK U.S.A.
  • Most recently, he was Senior Vice President and General Manager for the Handset Products Business at Qualcomm, responsible for Snapdragon chipset and software portfolio.
  • Earlier in his career, Jim took on engineering and management roles at Sony Corporation and Boeing.
  • TDK Corporation is a world leader in electronic solutions for the smart society based in Tokyo, Japan.

Highgate Continues to Assemble Best-in-Class Talent

Retrieved on: 
Tuesday, August 17, 2021

Jim McPartlin, formerly of Forbes Travel Guide, has joined Highgate as Chief People Officer to guide the organization's people and culture strategy.

Key Points: 
  • Jim McPartlin, formerly of Forbes Travel Guide, has joined Highgate as Chief People Officer to guide the organization's people and culture strategy.
  • Jeff Toscano has returned to Highgate as the Executive Vice President of Luxury and Lifestyle and will lead that division globally.
  • "Steve has been a trusted partner and friend over our three decades together and has been instrumental in everything that Highgate has accomplished," said Mahmood Khimji, Co-Founder and Managing Principal of Highgate.
  • As Chief People Officer at Highgate, Jim will ensure that Highgate remains an employer of choice and will strengthen the organization's community engagement, workforce development and diversity and inclusion strategy.

Industry Veteran Jim Caggiano Appointed CEO of Evolve Biologics®, As Company Advances Commercialization of Innovative PlasmaCap EBA® Technology to Disrupt $24 Billion Global Plasma-derived Therapeutics Market

Retrieved on: 
Tuesday, January 19, 2021

Evolve Biologics Inc. (Evolve), an innovative plasma-derived therapeutics company, today announced the appointment of Jim Caggiano as CEO.

Key Points: 
  • Evolve Biologics Inc. (Evolve), an innovative plasma-derived therapeutics company, today announced the appointment of Jim Caggiano as CEO.
  • Gabriel de Alba, Chairman of Evolve Biologics and Managing Director and Partner at Catalyst Capital Group Inc., Were excited to welcome Jim Caggiano to the Evolve team.
  • Jim Caggiano joins Evolve Biologics as CEO, after most recently serving as CEO of Dendreon Pharmaceuticals LLC.
  • Evolve Biologics and PlasmaCap EBA are registered trademarks of Evolve Biologics Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005560/en/